Parastoo Baradaran-Mashinchi, MD
Internal Medicine · Dawsonville, GANPI 1003494139
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $429, 9.8 times the $44 reported in 2021.
Across 54 payments — averaging $23.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$271
- Novo Nordisk$125
- Amgen$124
- Eisai Inc.$88
- E.r. Squibb & Sons, L.L.C.$84
- Melinta Therapeutics, LLC$68
- plus $527 from 17 others
What the payments were for
- Food & beverage$1,288100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 9 | $271 |
| Novo Nordisk | 7 | $125 |
| Amgen(2 entities) | 2 | $124 |
| Eisai Inc. | 3 | $88 |
| E.r. Squibb & Sons, L.L.C. | 5 | $84 |
| Melinta Therapeutics, LLC | 4 | $68 |
| GSK | 3 | $66 |
| Aurinia Pharma U.S., Inc. | 3 | $57 |
| Actelion Pharmaceuticals US, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Pfizer | 2 | $41 |
| Edwards Lifesciences | 1 | $36 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Medtronic | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Abbott | 1 | $20 |
| UCB, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,288 in reported general payments places this provider in the 70th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 41 | $277 |
| Atorvastatin Calcium | 24 | $249 |
| Gabapentin | 15 | $199 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $162 |
| Metformin Hcl | 17 | $154 |
| Metoprolol Succinate | 13 | $145 |
| Lisinopril | 12 | $95 |
| Methylprednisolone | 11 | $48 |
| Hydrochlorothiazide | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Dawsonville
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.